4.7 Article

CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression

Zizheng Chen et al.

Summary: This study identified up-regulated circCAMSAP1 in osteosarcoma, which promotes tumorigenesis through the circCAMSAP1/miR-145-5p/FLI1 pathway, suggesting it as a potential therapeutic target for human osteosarcoma.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Cell Biology

Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling

Xinya Gao et al.

Summary: The activation of EGFR signalling in GBM is driven by a newly discovered secretory E-cadherin protein variant called C-E-Cad encoded by circular RNA. This mechanism promotes tumorigenicity in glioma stem cells and provides a promising approach for treating EGFR-driven GBM by enhancing the efficacy of anti-EGFR strategies.

NATURE CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer

Hui Zhang et al.

Summary: The circular RNA circLIFR can positively modulate cisplatin sensitivity in bladder cancer by interacting with MSH2 through the MutS alpha/ATM-p73 axis, making them potential therapeutic targets for cisplatin-resistant bladder cancer.

MOLECULAR CANCER (2021)

Article Cell Biology

Circular RNA circSIPA1L1 Contributes to Osteosarcoma Progression Through the miR-411-5p/RAB9A Signaling Pathway

Yining Xu et al.

Summary: Recent studies have identified circSIPA1L1 as an upregulated circular RNA in osteosarcoma, which acts as a molecular sponge for miR-411-5p to increase RAB9A expression, promoting tumorigenesis. Silencing circSIPA1L1 attenuates the malignant properties of OS cells, and inhibition of miR-411-5p or overexpression of RAB9A reverses the anti-tumor effects caused by circSIPA1L1 knockdown.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC

Xiaosong Wang et al.

Summary: The study revealed that circACTN4 is upregulated in breast cancer tissues and cells, promoting tumor growth, invasion, and metastasis, and correlating with clinical stage and prognosis. circACTN4 interacts with FUBP1 to activate MYC transcription, facilitating breast cancer progression.

MOLECULAR CANCER (2021)

Article Oncology

CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760

Jianjun Yuan et al.

Summary: Our study demonstrated the role of circPRDM2/miR-760/EZH2 axis in enhancing DXR resistance in osteosarcoma, with circPRDM2 acting as a sponge for miR-760 and regulating EZH2 expression, ultimately affecting drug sensitivity and malignant behaviors. CircPRDM2 deficiency improved DXR sensitivity in vivo, highlighting the potential therapeutic implications of targeting this axis in chemoresistant cancers.

CANCER MANAGEMENT AND RESEARCH (2021)

Review Cell Biology

The potential of using blood circular RNA as liquid biopsy biomarker for human diseases

Guoxia Wen et al.

Summary: CircRNA, a novel class of single-stranded RNAs with a closed loop structure, plays important biological functions in various physiological processes and is implicated in many human diseases. Human blood circRNAs as liquid biopsy biomarkers show promise due to their high stability and potential translational applications.

PROTEIN & CELL (2021)

Review Oncology

RNA in cancer

Gregory J. Goodall et al.

Summary: Recent findings have shown that RNA processing is systematically altered in cancer, with mutations in RNA splicing factor genes and the shortening of 3' untranslated regions widely observed. Additionally, evidence suggests that other types of RNAs, including circular RNAs, can contribute to tumorigenesis.

NATURE REVIEWS CANCER (2021)

Review Biochemistry & Molecular Biology

Translation and functional roles of circular RNAs in human cancer

Ming Lei et al.

MOLECULAR CANCER (2020)

Review Cell Biology

Emerging landscape of circular RNAs as biomarkers and pivotal regulators in osteosarcoma

Chao Tu et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Review Cell Biology

The expanding regulatory mechanisms and cellular functions of circular RNAs

Ling-Ling Chen

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Biotechnology & Applied Microbiology

The regulatory functions of circular RNAs in osteosarcoma

Negin Soghli et al.

GENOMICS (2020)

Review Biochemistry & Molecular Biology

Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies

Ingrid Lilienthal et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

Shuying Shen et al.

MOLECULAR CANCER (2020)

Review Cardiac & Cardiovascular Systems

Circular RNAs open a new chapter in cardiovascular biology

Simona Aufiero et al.

NATURE REVIEWS CARDIOLOGY (2019)

Review Genetics & Heredity

The biogenesis, biology and characterization of circular RNAs

Lasse S. Kristensen et al.

NATURE REVIEWS GENETICS (2019)

Article Biochemistry & Molecular Biology

Circular RNA hsa_circ_0001564 regulates osteosarcoma proliferation and apoptosis by acting miRNA sponge

Yu-Ze Song et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Gastroenterology & Hepatology

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma

Jian Yu et al.

JOURNAL OF HEPATOLOGY (2018)

Review Pharmacology & Pharmacy

Circular RNA and its mechanisms in disease: From the bench to the clinic

Bing Han et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Oncology

Novel molecular insights and new therapeutic strategies in osteosarcoma

Babak Otoukesh et al.

CANCER CELL INTERNATIONAL (2018)

Review Biochemistry & Molecular Biology

CircRNA: functions and properties of a novel potential biomarker for cancer

Shujuan Meng et al.

MOLECULAR CANCER (2017)

Article Biochemistry & Molecular Biology

AUF1 facilitates microRNA-mediated gene silencing

Kyung-Won Min et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Oncology

miR-339-3p Is a Tumor Suppressor in Melanoma

Claudia E. M. Weber et al.

CANCER RESEARCH (2016)

Review Pharmacology & Pharmacy

Investigational therapies for Ewing sarcoma: a search without a clear finding

Olga Vornicova et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)

Review Genetics & Heredity

Detecting circular RNAs: bioinformatic and experimental challenges

Linda Szabo et al.

NATURE REVIEWS GENETICS (2016)

Review Genetics & Heredity

Circular RNA Expression: Its Potential Regulation and Function

Julia Salzman

TRENDS IN GENETICS (2016)

Article Biochemistry & Molecular Biology

The RNA Binding Protein Quaking Regulates Formation of circRNAs

Simon J. Conn et al.

Review Oncology

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Michael S. Isakoff et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Oncology

miR-339-3p inhibits proliferation and metastasis of colorectal cancer

Chang Zhou et al.

Oncology Letters (2015)

Review Oncology

Anti-angiogenic therapy, a new player in the field of sarcoma treatment

Yvonne M. H. Versleijen-Jonkers et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)

Review Biotechnology & Applied Microbiology

Detecting and characterizing circular RNAs

William R. Jeck et al.

NATURE BIOTECHNOLOGY (2014)

Article Cell Biology

TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells

Lynette J. Schedlich et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)

Article Multidisciplinary Sciences

Natural RNA circles function as efficient microRNA sponges

Thomas B. Hansen et al.

NATURE (2013)

Review Oncology

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

Jakob K. Anninga et al.

EUROPEAN JOURNAL OF CANCER (2011)